Literature DB >> 12409597

PET diagnostic accuracy: improvement with in-line PET-CT system: initial results.

Thomas F Hany1, Hans C Steinert, Gerhard W Goerres, Alfred Buck, Gustav K von Schulthess.   

Abstract

The authors describe the initial application for tumor staging with an in-line system with a positron emission tomographic (PET) scanner and a multi-detector row helical computed tomographic (CT) scanner combined in one machine. Fifty-three patients underwent imaging with four CT tube currents and PET emission and transmission data acquisition. Stepwise analysis of coregistered images revealed a significant (P <.05, McNemar test) improvement in lesion classification between PET images alone and coregistered images from the PET-CT examination. Copyright RSNA, 2002

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12409597     DOI： 10.1148/radiol.2252011568

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


  59 in total

1.  The impact of image fusion in resolving discrepant findings between FDG-PET and MRI/CT in patients with gynaecological cancers.

Authors:  Cheng-Chien Tsai; Chien-Sheng Tsai; Koon-Kwan Ng; Chyong-Huey Lai; Swei Hsueh; Pan-Fu Kao; Ting-Chang Chang; Ji-Hong Hong; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-08-21       Impact factor: 9.236

Review 2.  PET/CT and breast cancer.

Authors:  Barbara Zangheri; Cristina Messa; Maria Picchio; Luigi Gianolli; Claudio Landoni; Ferruccio Fazio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-05       Impact factor: 9.236

3.  Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT?

Authors:  Patrick Reinartz; Franz-Josef Wieres; Wolfram Schneider; Alexander Schur; Ulrich Buell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-10       Impact factor: 9.236

4.  The new-generation positron emission tomography/computed tomography scanners: implications for cardiac imaging.

Authors:  Stephen L Bacharach
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

5.  Multiphase contrast-enhanced CT with highly concentrated contrast agent can be used for PET attenuation correction in integrated PET/CT imaging.

Authors:  Philip Aschoff; Christian Plathow; Thomas Beyer; Matthias P Lichy; Gunter Erb; Mehmet Ö Öksüz; Claus D Claussen; Christina Pfannenberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-29       Impact factor: 9.236

6.  [Principles of PET/CT and clinical application].

Authors:  A Bockisch; T Beyer; G Antoch; P Veit; S Müller; R Pink; S Rosenbaum; H Kühl
Journal:  Radiologe       Date:  2004-11       Impact factor: 0.635

7.  Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer.

Authors:  G Mangili; M Picchio; S Sironi; R Viganò; E Rabaiotti; D Bornaghi; V Bettinardi; C Crivellaro; C Messa; F Fazio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-20       Impact factor: 9.236

8.  Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT.

Authors:  W De Wever; S Ceyssens; L Mortelmans; S Stroobants; G Marchal; J Bogaert; J A Verschakelen
Journal:  Eur Radiol       Date:  2006-05-09       Impact factor: 5.315

9.  Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.

Authors:  Anees B Chagpar; Lavinia P Middleton; Aysegul A Sahin; Peter Dempsey; Aman U Buzdar; Attiqa N Mirza; Fredrick C Ames; Gildy V Babiera; Barry W Feig; Kelly K Hunt; Henry M Kuerer; Funda Meric-Bernstam; Merrick I Ross; S Eva Singletary
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

10.  Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?

Authors:  Markus Selzner; Thomas F Hany; Peer Wildbrett; Lucas McCormack; Zakiyah Kadry; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.